Table 5 Final regression models (ReTransQol domains)
Dimensions | Variables | B coeff. | 95% CI | P values |
|---|---|---|---|---|
PH R2 = 0.31 | Intercept | 78.2 | [75.2; 81.2] | p < .0001 |
| Â | Female | -2.5 | [-4.5; -0.5] | p < 0.0156 |
| Â | Low educational (primary or less) | -7.3 | [-9.6; -5.1] | p < .0001 |
| Â | BMI > 30 (kg/m2) | -4.6 | [-7.4; -1.7] | p < 0.0021 |
| Â | Unemployment | -7.2 | [-9.4; -5.1] | p < .0001 |
| Â | Duration of dialysis > 3Â years | -2.5 | [-4.7; -0.4] | p < 0.0226 |
| Â | Hospitalization in the last 4Â weeks | -5.2 | [-8.6; -1.8] | p < 0.0029 |
| Â | Critical illness in the last 4Â weeks | -6 | [-10.6; -1.4] | p < 0.0110 |
| Â | Side effects related to general health | -9.8 | [-12.5; -7] | p < .0001 |
| Â | Side effects related to mental health | -6 | [-8.7; -3.3] | p < .0001 |
| Â | Side effects related to body modification | -4.4 | [-6.6; -2.2] | p < .0001 |
MH R2 = 0.27 | Intercept | 87 | [84.1; 89.9] | p < .0001 |
| Â | Female | -4.1 | [-6.1; -2.2] | p < .0001 |
| Â | Family status (living alone) | -8.1 | [-10.3; -5.8] | p < .0001 |
| Â | Dismissal | -3.7 | [-6.7; -0.7] | p < 0.0152 |
| Â | Duration of dialysis > 3Â years | -3.9 | [-5.9; -1.8] | p < 0.0003 |
| Â | Hospitalization in the last 4Â weeks | -5.1 | [-8.3; -2] | p < 0.0014 |
| Â | Recent surgery | -10.3 | [-18.2; -2.4] | p < 0.0107 |
| Â | Side effects related to general health | -6.4 | [-9.1; -3.7] | p < .0001 |
| Â | Side effects related to mental health | -10.2 | [-12.8; -7.5] | p < .0001 |
| Â | Side effects related to body modification | -3.7 | [-5.9; -1.6] | p < 0.0007 |
MC R2 = 0.1 | Intercept | 79.2 | [78; 80.5] | p < .0001 |
| Â | Family status (living alone) | -3.8 | [-5.9; -1.7] | p < 0.0004 |
| Â | Dismissal | -3.1 | [-6; -0.2] | p < 0.0354 |
| Â | Side effects related to general health | -5.9 | [-8.4; -3.3] | p < .0001 |
| Â | Side effects related to mental health | -3.6 | [-6.1; -1] | p < 0.0056 |
| Â | Side effects related to body modification | -2.9 | [-4.9; -0.8] | p < 0.0057 |
TR R2 = 0.31 | Intercept | 77.4 | [76.4; 78.4] | p < .0001 |
| Â | BMI > 30 (kg/m2) | -3.2 | [-5.3; -1.1] | p < 0.0030 |
| Â | Non-compliant | -4.4 | [-6.1; -2.7] | p < .0001 |
| Â | Side effects related to general health | -9.5 | [-11.5; -7.5] | p < .0001 |
| Â | Side effects related to mental health | -6.8 | [-8.8; -4.8] | p < .0001 |
| Â | Side effects related to body modification | -7.5 | [-9.1; -5.9] | p < .0001 |
FG R2 = 0.1 | Intercept | 66.5 | [62.3; 70.7] | p < .0001 |
| Â | Female | -3 | [-5.8; -0.1] | p < 0.0409 |
| Â | Side effects related to mental health | -11.4 | [-15.1; -7.7] | p < .0001 |
| Â | Side effects related to body modification | -4.9 | [-7.9; -1.8] | p < 0.0016 |